Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Condition:   Tuberculosis Interventions:   Biological: GamTBvac;   Biological: Placebo Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Acceptability and Feasibility of Home-based TB Testing
Conditions:   Tuberculosis, Pulmonary;   Households Intervention:   Diagnostic Test: Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test Sponsors:   Foundation for Professional Development (Pty) Ltd;   National Institutes of Health (NIH);   National Institute for Biomedical Imaging and Bioengineering (NIBIB);   Medical Research Council, South Africa;   Foundation for Innovative New Diagnostics, Switzerland;   University of  Witwatersrand, South Africa;   Uni...
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

Impact of Malnutrition on Pharmacokinetic or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-infected Children
Conditions:   Tuberculosis;   Pulmonary Intervention:   Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials

TuBerculosis Viability Interregional Study and Agreement on Biological Tests
Condition:   Tuberculosis, Pulmonary Intervention:   Diagnostic Test: Diagnostic Test: viability test on sputum and comparision with culture results (reference test) Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2021 Category: Research Source Type: clinical trials

COPD Co-infection With Tuberculosis on Th17 Cell Differentiation
Conditions:   Tuberculosis Infection;   Chronic Obstructive Pulmonary Disease Intervention:   Other: No intervention Sponsors:   Peking University Third Hospital;   Beijing Geriatric Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2021 Category: Research Source Type: clinical trials

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis
Conditions:   Disseminated Tuberculosis;   HIV Interventions:   Drug: Rifampin;   Drug: Prednisone;   Drug: Placebo;   Drug: Rifamp/Isoniazid/Pyrazinamide 120 Mg-50 Mg-300 Mg ORAL TABLET;   Drug: Levofloxacin Sponsor:   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2021 Category: Research Source Type: clinical trials